Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation
Clinical trial NCT02325362 · COMPLETED
Trial details
- NCT number
- NCT02325362
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-17
- Primary completion
- 2017-04-03
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.